Literature DB >> 10068372

Severe hepatotoxicity associated with troglitazone.

S K Herrine, C Choudhary.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068372     DOI: 10.7326/0003-4819-130-2-199901190-00021

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  The glitazones: proceed with caution.

Authors:  D Krische
Journal:  West J Med       Date:  2000-07

Review 2.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

3.  Assessment of compound hepatotoxicity using human plateable cryopreserved hepatocytes in a 1536-well-plate format.

Authors:  Timothy A Moeller; Sunita J Shukla; Menghang Xia
Journal:  Assay Drug Dev Technol       Date:  2011-11-04       Impact factor: 1.738

Review 4.  Hepatotoxicity with thiazolidinediones: is it a class effect?

Authors:  A J Scheen
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 5.  Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.

Authors:  Raúl-J Andrade; Mercedes Robles; Alejandra Fernández-Castañer; Susana López-Ortega; M-Carmen López-Vega; M-Isabel Lucena
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

6.  Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.

Authors:  Herbert L Bonkovsky; Riad Azar; Steven Bird; Gyongyi Szabo; Barbara Banner
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

7.  Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone.

Authors:  N L Julie; I M Julie; A I Kende; G L Wilson
Journal:  Diabetologia       Date:  2008-08-23       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.